Financings in Brief: Cytyc
This article was originally published in The Gray Sheet
Executive Summary
Cytyc: Files with SEC for an offering of 3 mil. shares, including 2 mil. to be sold by the company and 1 mil. by selling shareholders. Proceeds from the offering will support U.S. sales and marketing of the company's ThinPrep system for cervical cancer screening, and will help establish international sales and marketing, Cytyc says. Underwriters for the offering, led by Robertson, Stephens & Company, Montgomery Securities, and Piper Jaffray, have an over-allotment option to purchase 450,000 additional shares...